Are VEGFR-TKIs Effective or Safe for Patients With Advanced Non-Small Cell Lung Cancer?

Oncotarget - United States
doi 10.18632/oncotarget.4524
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Nondisruptive P53 Mutations Are Associated With Shorter Survival in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy of EGFR-TKIs With or Without Angiogenesis Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Cancer
Oncology
2020English

Impact of ABCG2 Polymorphisms on the Clinical Outcome of TKIs Therapy in Chinese Advanced Non-Small-Cell Lung Cancer Patients

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

The Impact of Rescue or Maintenance Therapy With EGFR TKIs for Stage IIIb-IV Non-Squamous Non-Small-Cell Lung Cancer Patients Requiring Mechanical Ventilation

BMC Anesthesiology
AnesthesiologyPain Medicine
2014English

Are We Really Operating on Advanced Stage Non-Small Cell Lung Cancer?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy